In the research, Dalmau showed that 75% of the patients with NMDAR encephalitis recover entirely or with mild sequelae while the other 25% have severe CNS deficits or eventually die.

In a study using the data obtained from 382 patients aged between 1 to 85 years, Balu et al. devised a five-point predictions score, Anti-NMDAR encephalitis 1-year functioning status (NEOS) score.